THU0503 Cost Analysis of Anti-Osteoporotic Drugs in Real-World Clinical Practice

doi 10.1136/annrheumdis-2018-eular.6620
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism

Related search

THU0474 Utilisation of Anti-Osteoporotic Drugs in Real-World Data: An Analysis of Persistence to Therapy and Risk of Fracture

2018English

Pnd31 - Cost Analysis of Botulinum Toxin a (Botox® and Xeomin®) in Real-World Clinical Practice

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Bone Regeneration Using Anti-Osteoporotic Drugs in Adjunction With Bone Grafting: A Meta-Analysis

Tissue Engineering - Part B: Reviews
BiochemistryBioengineeringBiomaterialsBiomedical Engineering
2019English

Analysis of Real-World Database: Endometriosis Treatment Practice in Ukraine

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Pharmacogenetics of Non-Steroidal Anti-Inflammatory Drugs: Existing Problems for Clinical Practice

Medical Council
2019English

The Risk/Benefit Profile of Biologic Drugs in Real-World Rheumatology Practice. From ANTARES to MonitorNet

Reumatismo
Rheumatology
2011English

PEARL: A Non-Interventional Study of Real-World Alirocumab Use in German Clinical Practice

Drugs - Real World Outcomes
Pharmacology
2019English

Cn8 - Cost-Effectiveness Analysis of Oral Cancer Screening in Taiwan: A Real World Data Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

5psq-075 Safety Profile of Fingolimod in Real World Clinical Practice: A Preliminary Study

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy